McKesson Corp. (MCK): Price and Financial Metrics

McKesson Corp. (MCK): $532.00

4.68 (+0.89%)

POWR Rating

Component Grades

Momentum

C

Stability

B

Sentiment

Quality

C

Add MCK to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#6 of 66

in industry

MCK Price/Volume Stats

Current price $532.00 52-week high $543.00
Prev. close $527.32 52-week low $352.34
Day low $527.89 Volume 490,700
Day high $532.86 Avg. volume 688,891
50-day MA $525.15 Dividend yield 0.48%
200-day MA $467.49 Market Cap 69.91B

MCK Stock Price Chart Interactive Chart >


McKesson Corp. (MCK) Company Bio


McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 78,000 employees. McKesson had revenues of $238.2 billion in its fiscal year ending March 31, 2021. (Source:Wikipedia)


MCK Latest News Stream


Event/Time News Detail
Loading, please wait...

MCK Latest Social Stream


Loading social stream, please wait...

View Full MCK Social Stream

Latest MCK News From Around the Web

Below are the latest news stories about MCKESSON CORP that investors may wish to consider to help them evaluate MCK as an investment opportunity.

Silver Economy Successes: 3 Stocks Benefitting From an Aging Population

Explore our in-depth analysis of aging population stocks, uncovering the opportunities and challenges in this sector.

Faizan Farooque on InvestorPlace | December 27, 2023

McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference

IRVING, Texas, December 27, 2023--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2024 financial results after market close on Wednesday, February 7, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.

Yahoo | December 27, 2023

McKesson (MCK) Announces Availability of PNH's FDA-Approved Drug

The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for PNH.

Yahoo | December 26, 2023

McKesson's (NYSE:MCK) five-year earnings growth trails the 34% YoY shareholder returns

For many, the main point of investing in the stock market is to achieve spectacular returns. And we've seen some truly...

Yahoo | December 23, 2023

Why McKesson (MCK) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Yahoo | December 22, 2023

Read More 'MCK' Stories Here

MCK Price Returns

1-mo -0.11%
3-mo 9.82%
6-mo 18.09%
1-year 47.79%
3-year 176.66%
5-year 381.32%
YTD 15.04%
2023 24.13%
2022 51.82%
2021 44.23%
2020 27.06%
2019 26.72%

MCK Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MCK Dividend History

Continue Researching MCK

Here are a few links from around the web to help you further your research on Mckesson Corp's stock as an investment opportunity:

Mckesson Corp (MCK) Stock Price | Nasdaq
Mckesson Corp (MCK) Stock Quote, History and News - Yahoo Finance
Mckesson Corp (MCK) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!